English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Hydrogen sulfide (H 2 S) exhibits beneficial effects in the cardiovascular system, many of which depend on nitric oxide (NO). Proline-rich tyrosine kinase 2 (PYK2), a redox-sensitive tyrosine kinase, directly phosphorylates and inhibits endothelial NO synthase (eNOS). We investigated the ability of H 2 S to relieve PYK2-mediated eNOS inhibition and evaluated the importance of the H 2 S/PYK2/eNOS axis on cardiomyocyte injury in vitro and in vivo. Exposure of H9c2 cardiomyocytes to H 2 O 2 or pharmacologic inhibition of H 2 S production increased PYK2 (Y402) and eNOS (Y656) phosphorylation. These effects were blocked by treatment with Na 2 S or by overexpression of cystathionine γ -lyase (CSE). In addition, PYK2 overexpression reduced eNOS activity in a H 2 S-reversible manner. The viability of cardiomyocytes exposed to Η 2 Ο 2 was reduced and declined further after the inhibition of H 2 S production. PYK2 downregulation, l-cysteine supplementation, or CSE overexpression alleviated the effects of H 2 O 2 on H9c2 cardiomyocyte survival. Moreover, H 2 S promoted PYK2 sulfhydration and inhibited its activity. In vivo, H 2 S administration reduced reactive oxygen species levels, as well as PYK2 (Y402) and eNOS (Y656) phosphorylation. Pharmacologic blockade of PYK2 or inhibition of PYK2 activation by Na 2 S reduced myocardial infarct size in mice. Coadministration of a PYK2 inhibitor and Na 2 S did not result in additive effects on infarct size. We conclude that H 2 S relieves the inhibitory effect of PYK2 on eNOS, allowing the latter to produce greater amounts of NO, thereby affording cardioprotection. Our results unravel the existence of a novel H 2 S-NO interaction and identify PYK2 as a crucial target for the protective effects of H 2 S under conditions of oxidative stress.

molecular pharmacology

Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection